Neuralgia Clinical Trials

Find Neuralgia Clinical Trials Near You

Development of a Novel Evaluation Scale of Mental Body Representation (MBR) for Adults With Spinal Cord Injury

Status: Recruiting
Location: See location...
Intervention Type: Other
Study Type: Observational
SUMMARY

The purpose of this study is twofold: (1) Develop a new evaluation scale for mental body representations (MBR, i.e., body awareness and visuospatial body maps) for adults with spinal cord injury (SCI) with and without neuropathic pain. (2) Assess the psychometric properties of usability, reliability, and validity of the new evaluation scale This is a cross-sectional observational study design. For Aim 1, this study will involve initial item generation for a novel MBR evaluation scale for SCI through email communication, and individual interviews proctored remotely through Zoom, or, if preferred by the participant, in-person. For Aim 2, the study will include a Zoom call for consenting and questionnaires, as well as an in-person visit where participants will be tested with the new SCI-BodyMap evaluation scale, and a questionnaire asking about the usability and satisfaction of the new evaluation scale.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: t
View:

⁃ Control group

• Uninjured adults (from the contact list with the Brain Body Mind lab or through fliers or StudyFinder)

• 18+ years old adults

⁃ SCI group

• 18+ years old, participants with an incomplete or complete SCI of ≥ 1 year

• medically stable

• able to read and understand English

• having access to the internet/iPad/computer/phone and willing to come in for an in-person testing at the University of Minnesota.

Locations
United States
Minnesota
University of Minnesota
RECRUITING
Minneapolis
Contact Information
Primary
Sydney Carpentier
carpe749@umn.edu
562-508-9693
Time Frame
Start Date: 2024-11-18
Estimated Completion Date: 2027-06-15
Participants
Target number of participants: 80
Treatments
Participants with SCI
Uninjured participants
Related Therapeutic Areas
Sponsors
Leads: University of Minnesota

This content was sourced from clinicaltrials.gov